SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Apr-22 7:14 PM View: | Sana Biotechnology, Inc. (SANA) | 14-Apr-21 | Gift | 334,000 | -- | -- | (4%) 9.19M to 8.86M | |
10-Feb-21 6:53 PM View: | Sana Biotechnology, Inc. (SANA) | 08-Feb-21 | Conversion | 2,031,250 | -- | -- | 30% 6.83M to 8.86M | |
07-Mar-18 6:20 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Mar-18 | Disposition | 147,162 | $29.57 | $4,350,870.00 | (23%) 639.52K to 492.36K | |
07-Mar-18 6:20 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Mar-18 | Disposition (change in control) | 492,355 | $87.00 | $42,834,900.00 | (100%) 492.36K to 0 | |
01-Mar-18 6:23 PM View: | Juno Therapeutics, Inc. (JUNO) | 27-Feb-18 | Grant | 11,544 | -- | -- | 2% 627.97K to 639.52K | |
09-Feb-18 7:32 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Feb-18 | Payment of Exercise | 1,704 | $85.49 | $145,675.00 | (< 1%) 792.47K to 790.76K | |
09-Feb-18 7:32 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Feb-18 | Gift | 162,790 | -- | -- | (21%) 790.76K to 627.97K | |
02-Feb-18 7:31 PM View: | Juno Therapeutics, Inc. (JUNO) | 31-Jan-18 | Grant | 29,135 | -- | -- | 4% 763.33K to 792.47K | |
22-Dec-17 4:59 PM View: | Juno Therapeutics, Inc. (JUNO) | 21-Dec-17 | Option Exercise | 8,750 | $8.72 | $76,300.00 | 1% 763.33K to 772.08K | |
22-Dec-17 4:59 PM View: | Juno Therapeutics, Inc. (JUNO) | 21-Dec-17 | Market Option Sale (Planned) | 8,750 | $44.76 | $391,674.00 | (1%) 772.08K to 763.33K | |
20-Oct-17 8:27 PM View: | Juno Therapeutics, Inc. (JUNO) | 20-Oct-17 | Grant | 35,893 | -- | -- | 5% 727.44K to 763.33K | |
05-Jul-17 6:41 PM View: | Juno Therapeutics, Inc. (JUNO) | 03-Jul-17 | Option Exercise | 8,750 | $8.72 | $76,300.00 | 1% 727.44K to 736.19K | |
05-Jul-17 6:41 PM View: | Juno Therapeutics, Inc. (JUNO) | 03-Jul-17 | Market Option Sale | 8,750 | $30.00 | $262,500.00 | (1%) 736.19K to 727.44K | (189%) |
29-Jun-17 7:43 PM View: | Juno Therapeutics, Inc. (JUNO) | 27-Jun-17 | Option Exercise | 8,750 | $8.72 | $76,300.00 | 1% 727.44K to 736.19K | |
29-Jun-17 7:43 PM View: | Juno Therapeutics, Inc. (JUNO) | 27-Jun-17 | Market Option Sale | 8,750 | $30.00 | $262,501.00 | (1%) 736.19K to 727.44K | (189%) |
09-Feb-17 7:35 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Feb-17 | Grant | 27,439 | -- | -- | 4% 700.0K to 727.44K | |
13-Jun-16 7:20 AM View: | Juno Therapeutics, Inc. (JUNO) | 10-Jun-16 | Market Sale | 30,000 | $43.32 | $1,299,530.00 | (4%) 730.0K to 700.0K | 39% |
04-Mar-16 9:00 PM View: | Juno Therapeutics, Inc. (JUNO) | 04-Mar-16 | Market Sale | 5,000 | $45.00 | $225,000.00 | (< 1%) 735.0K to 730.0K | (136%) |
02-Mar-16 9:03 PM View: | Juno Therapeutics, Inc. (JUNO) | 01-Mar-16 | Market Sale | 30,000 | $37.58 | $1,127,340.00 | (4%) 765.0K to 735.0K | (183%) |
11-Dec-15 9:00 PM View: | Juno Therapeutics, Inc. (JUNO) | 10-Dec-15 | Market Sale | 35,000 | $46.43 | $1,625,070.00 | (4%) 800.0K to 765.0K | (129%) |